Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1175 of 3173 entries
View as:

Sayana Press UK Self-Injection Study

Phase: N/A Priority: Normal
NCT ID: NCT03034057 Org: User:
Start: 08/23/17 End: 12/07/18 Due: 12/07/19

Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01421069 Org: User:
Start: 10/10/11 End: 02/04/21 Due: 02/04/22

PF-00477736 Is Being Studied In Advanced Solid Tumors In Combination With Chemotherapy With Gemcitabine

Phase: N/A Priority: Normal
NCT ID: NCT00437203 Org: User:
Start: 12/31/06 End: 04/30/11 Due: 04/30/12

Efficacy Study Of Tofacitinib In Pediatric JIA Population

Phase: N/A Priority: Normal
NCT ID: NCT02592434 Org: User:
Start: 06/10/16 End: 05/16/19 Due: 05/16/20

Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT04881045 Org: User:
Start: 08/18/21 End: 10/24/23 Due: 10/24/24

Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00752232 Org: User:
Start: 12/31/08 End: 07/31/12 Due: 07/31/13

Pfizer-BioNTech COVID-19 Vaccine Effectiveness Study - Kaiser Permanente Southern California

Phase: N/A Priority: Normal
NCT ID: NCT04848584 Org: User:
Start: 05/15/21 End: 06/15/25 Due: 06/15/26

A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05545319 Org: User:
Start: 12/13/22 End: 01/06/24 Due: 01/06/25

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

Phase: N/A Priority: Normal
NCT ID: NCT00141336 Org: User:
Start: 11/30/99 End: 07/31/05 Due: 07/31/06

Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).

Phase: N/A Priority: Normal
NCT ID: NCT02475733 Org: User:
Start: 08/01/15 End: 06/01/17 Due: 06/01/18

Tanezumab In Osteoarthritis Of The Hip Or Knee

Phase: N/A Priority: Normal
NCT ID: NCT00985621 Org: User:
Start: 10/30/09 End: 02/04/11 Due: 02/04/12

Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database

Phase: N/A Priority: Normal
NCT ID: NCT05286528 Org: User:
Start: 11/18/20 End: 01/31/22 Due: 01/31/23

A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00879554 Org: User:
Start: 02/28/07 End: 11/30/10 Due: 11/30/11

6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent Albuminuria

Phase: N/A Priority: Normal
NCT ID: NCT00287183 Org: User:
Start: 02/28/06 End: 08/31/09 Due: 08/31/10

A Single Dose Crossover Study In Healthy Subjects To Evaluate Different Formulations Of PF-06882961

Phase: N/A Priority: Normal
NCT ID: NCT03492697 Org: User:
Start: 04/30/18 End: 07/18/18 Due: 07/18/19

Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization

Phase: N/A Priority: Normal
NCT ID: NCT00508742 Org: User:
Start: 12/31/07 End: 08/31/11 Due: 08/31/12

A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01999972 Org: User:
Start: 02/26/14 End: 09/05/19 Due: 09/05/20

Korean Post-marketing Surveillance for Xeljanz

Phase: N/A Priority: Normal
NCT ID: NCT02984020 Org: User:
Start: 05/13/16 End: 06/09/22 Due: 06/09/23

Post Marketing Surveillance Study For Sayana®

Phase: N/A Priority: Normal
NCT ID: NCT02104557 Org: User:
Start: 02/13/14 End: 06/05/20 Due: 06/05/21

A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization

Phase: N/A Priority: Normal
NCT ID: NCT00797108 Org: User:
Start: 01/31/09 End: 06/30/09 Due: 06/30/10

Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01193608 Org: User:
Start: 09/30/10 End: 10/31/13 Due: 10/31/14

Evaluation Of The Impact Of A Call Center In Management Of Metastatic And/Or Advanced Renal Cell Carcinoma Patients Treated With Sunitinib (Sutent) In First Line

Phase: N/A Priority: Normal
NCT ID: NCT02187042 Org: User:
Start: 10/07/15 End: 07/25/18 Due: 07/25/19

A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT05810038 Org: User:
Start: 05/15/23 End: 12/15/25 Due: 12/15/26

A Study To Investigate The Safety And Toleration Of Multiple Oral Doses Of PF-03654764 In Combination With Fexofenadine In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01298505 Org: User:
Start: 06/04/10 End: 06/04/10 Due: 06/04/11

Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00220376 Org: User:
Start: 04/30/04 End: 07/31/07 Due: 07/31/08